1. Home
  2. SCPH vs GWRS Comparison

SCPH vs GWRS Comparison

Compare SCPH & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • GWRS
  • Stock Information
  • Founded
  • SCPH 2013
  • GWRS 2003
  • Country
  • SCPH United States
  • GWRS United States
  • Employees
  • SCPH N/A
  • GWRS N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • GWRS Water Supply
  • Sector
  • SCPH Health Care
  • GWRS Utilities
  • Exchange
  • SCPH Nasdaq
  • GWRS Nasdaq
  • Market Cap
  • SCPH 274.7M
  • GWRS 300.3M
  • IPO Year
  • SCPH 2017
  • GWRS 2010
  • Fundamental
  • Price
  • SCPH $3.41
  • GWRS $12.94
  • Analyst Decision
  • SCPH Strong Buy
  • GWRS
  • Analyst Count
  • SCPH 2
  • GWRS 0
  • Target Price
  • SCPH $15.00
  • GWRS N/A
  • AVG Volume (30 Days)
  • SCPH 494.3K
  • GWRS 21.1K
  • Earning Date
  • SCPH 11-13-2024
  • GWRS 11-06-2024
  • Dividend Yield
  • SCPH N/A
  • GWRS 2.32%
  • EPS Growth
  • SCPH N/A
  • GWRS N/A
  • EPS
  • SCPH N/A
  • GWRS 0.27
  • Revenue
  • SCPH $30,278,000.00
  • GWRS $51,809,000.00
  • Revenue This Year
  • SCPH $195.62
  • GWRS $2.72
  • Revenue Next Year
  • SCPH $145.07
  • GWRS $3.56
  • P/E Ratio
  • SCPH N/A
  • GWRS $48.33
  • Revenue Growth
  • SCPH 303.87
  • GWRS 0.10
  • 52 Week Low
  • SCPH $3.08
  • GWRS $11.15
  • 52 Week High
  • SCPH $6.71
  • GWRS $13.98
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 32.05
  • GWRS 54.91
  • Support Level
  • SCPH $3.25
  • GWRS $12.69
  • Resistance Level
  • SCPH $3.60
  • GWRS $13.01
  • Average True Range (ATR)
  • SCPH 0.23
  • GWRS 0.35
  • MACD
  • SCPH -0.07
  • GWRS -0.00
  • Stochastic Oscillator
  • SCPH 18.95
  • GWRS 41.39

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About GWRS Global Water Resources Inc.

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operate within the State of Arizona.

Share on Social Networks: